Predictive biomarker for hypoxia-activated prodrug therapy
- 专利权人:
- 发明人:
- Brian A. Elenbaas,Lei Shen
- 申请号：
- US15035131
- 公开号：
- US10071109B2
- 申请日:
- 2014.10.28
- 申请国别(地区):
- US
- 年份:
- 2018
- 代理人:
- 摘要：
- CYP2W1 levels are predictive of the probability that a cancer patient will respond favorably to cancer therapy involving administration of a hypoxia-activated achiral phosphoramidate mustards.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- PREDICTIVE BIOMARKER FOR HYPOXIA-ACTIVATED PRODRUG THERAPY
- Method of Treating Cancer with a Cancer Therapy in Combination with Another Therapeutic Agent
- Method for prediction of therapeutic effect of chemotherapy on breast cancer patient
- Predicting response to cancer therapy
- PREDICTING RESPONSE TO CANCER THERAPY
